We join forces with rare individuals who make the whole of our network greater than the sum of its parts. We refuse to think of our founders as a “portfolio” – instead, we’re cultivating a Guild.
NASDAQ – TWST
Market-Network for synthetic biology industry
Acquired by Twist Bioscience
The CRISPR data platform
Co-Investors – Mayfield, 8VC, Danhua Capital, Decheng Capital
Bio platform for monitoring treatment response for various types of solid cancer
Novel capabilities in bioluminescence through synthetic biology
Technology platform for safe/effective delivery of biologics to the brain
Therapeutics company treating the incurable
Novel delivery platform for in-vivo gene editing
Exploring programmable therapies
Gilboa Therapeutics develops a novel cell therapy for solid cancers
To see the full library of Bio-related content, click here.
NFX Bio Insights delivered weekly to your inbox